Patent Description:
Water is the foundation of all life on earth. Every part of the body is dependent on water. The functions of our glands and organs will eventually deteriorate if they are not nourished with good clean water. Metabolism, digestion, blood flow and cellular reproduction all depend on proper water supply.

Molecular resonance effect technology has been previously described in <CIT>. This technology imprints a subtle low frequency electromagnetic field into a body of water, which changes the clathrate structure of the water, thereby creating a long-range dynamic multilayer water molecular structure similar to the structures of cell waters in biological systems. Structural changes in the water clathrate after activation have been confirmed by Nuclear Magnetic Resonance and High Voltage Photography testing.

While Molecular resonance effect technology is itself a known process for activating liquids, its production has been limited to small scale, such as the treatment of one or a few gallons of water. Described herein are systems and methods for a significantly larger scale production of activated water and newly developed uses for activated liquids, such as activated water, that until now have remained unknown.

The invention discloses a large scale system for the activation of water and discloses additional uses of water that has been activated via molecular resonance effect technology.

In particular, disclosed is a large scale system for the activation of water or an aqueous liquid, the system including: at least two activation tanks for storing water or aqueous liquid during activation and having a switch that indicates the tank is full, wherein the switch is operably connected to a controller with control panel that instructs a valve to close when receiving a stop signal from the switch, thereby stopping the flow of water into the tank when full; an activation assembly operably connected to each activation tank, each activation assembly having: a solenoid having a column wrapped in wiring, wherein the solenoid is configured to generate a magnetic field between <NUM>,<NUM> and A/m and <NUM>,<NUM>,<NUM> A/m (<NUM>,<NUM> and <NUM>,<NUM> Oersteds); a polymeric composition held within the column and exposed to the magnetic field, the polymeric composition composed of a polymer having a linear chain length of at least <NUM> monomer units, and dispersed within the polymeric composition is a mixture having between <NUM> -<NUM> parts by weight per <NUM> parts by weight of polymer, at least one element from each of two classes: a first class being a metal, metal oxide, metal nitrate and/or a metal sulfate, a second class being an inorganic acid, and a third class being an aminoaldehyde; a cluster of light emitted diodes (LEDs) emitting at the polymer composition, an emission wavelength between <NUM> and <NUM>, the cluster of LEDS configured to flash at a frequency between <NUM> and <NUM>; and a means for powering the activation assembly. According to the invention, each activation tank stores at least <NUM> liters (<NUM>,<NUM> gallons) of liquid during activation and each column holds at least <NUM>,<NUM><NUM> of the polymeric composition.

In preferred embodiments, for each of two <NUM>,<NUM> liters (<NUM> gallon) activation tanks, the corresponding activation assembly includes <NUM> LEDs, and the polymeric composition has a volume of about <NUM>,<NUM><NUM>. In some embodiments, the system also includes a reverse osmosis system upstream of the liquid activation assembly.

Also disclosed is a method of water activation and thus aqueous liquid or solution activation, which includes the steps of: providing the large scale system for the activation of water or aqueous liquid; filling each of two activation tanks with water; powering the activation assembly to produce magnetic field between <NUM>,<NUM> and A/m and <NUM>,<NUM>,<NUM> A/m (<NUM>,<NUM> and <NUM>,<NUM> Oersteds) and flashing the LEDs a frequency between <NUM> and <NUM> for at least <NUM> hour, thereby inducing low frequency oscillations of <NUM> to <NUM> and exposing the low frequency oscillations to water within the activation tanks.

Also disclosed is use of the activated water for reducing or inhibiting tumor cell proliferation. The approach includes, after the activation, exposing tumor cells to the activated water. In another embodiment the approach includes providing a subject suffering from or at risk of suffering from tumor cell proliferation, activating water or an aqueous liquid according to the method of water or aqueous liquid activation using the large scale system for the activation of water; and administering the activated water or liquid containing the activated water to the subject daily.

Also disclosed is the use of the activated water for enhancing NK cell killing of tumor cells. The approach includes, after activation, exposing NK cells to the activated water or a liquid containing activated water, where the water is activated according to the method of water activation using the large scale system for the activation of water or liquid; and exposing the NK cells to tumor cells.

Also disclosed is use of the activated water for preventing or reducing amyloid plaques. The approach includes providing a subject suffering from or at risk of suffering from the formation of amyloid plaques; activating water according to the method of water activation using the large scale system for the activation of water; and administering the activated water or liquid containing the activated water to the subject daily.

Also disclosed is use of the activated water for preventing or ameliorating effects of a skin disorder. The approach includes providing a subject suffering from or at risk of suffering from a skin disorder; activating water according to the method of water activation using the large scale system for the activation of water; and administering the activated water or liquid containing the activated water to the subject. In some embodiments, the skin disorder is psoriasis. In some embodiments, the activated water or liquid is a component of a cream or gel. In some embodiments the activated water is applied topically.

Also disclosed is use of the activated water for reducing or inhibiting microbial growth. The approach includes applying to a surface at risk of microbial growth, a composition including activated water or a liquid containing activated water, where the activated water is activated according to the method of water activation using the large scale system for the activation of water. The activated water is substantially free of anti-microbial additives, thereby relying on the activated water itself for antimicrobial effect.

Also disclosed is use of the activated water for enhancing the effects of an antibiotic. The approach includes providing a surface at risk of microbial growth; and administering an antibiotic in combination with the activated water, where the activated water is activated according to the method of water activation using the large scale system for the activation of water or liquid.

Also disclosed is the use of activated water for accelerating seed germination. The approach includes activating water according to the method of water activation using the large scale system for the activation of water; and maintaining a plant seed under moist conditions through germination, wherein the moisture is from the activated water.

Also disclosed is use of the activated water for reducing or inhibiting viral invasion of human cells, such as by SARS-CoV. The approach includes providing a subject having cells at risk of viral invasion; activating water according to the method of water activation using the large scale system for the activation of water; and administering the activated water or liquid containing the activated water to the subject daily.

Also disclosed is use of the activated water for preventing or reducing bacterial infection, such as by Staphylococcus. The approach includes providing a subject at risk of bacterial infection; activating water according to the method of water activation using the large scale system for the activation of water; and administering the activated water or liquid containing the activated water to the subject daily.

The invention can be more easily understood, and further advantages and uses thereof can be more readily apparent, when considered in view of the detailed description and the following drawings.

The present disclosure expands upon the disclosure of <CIT>, by the same inventor, which describes a device and method for the activation of liquids using a technology referred to as molecular resonance effect technology (MRET). Broadly, the activation device includes a polymeric body into which is incorporated small quantities of inorganic and organic materials. As will be described in more detail in the passages that follow, the polymeric body is simultaneously exposed to strong electromagnetic field and a cluster of yellow LEDs flashing at a frequency of <NUM> or about <NUM>. Simultaneously exposing the polymeric body to each causes the emission of a low-frequency resonant electromagnetic field. When exposing a body of liquid such as water or other aqueous solution (e.g. cell culture media or other water based liquids) to this low-frequency resonant electromagnetic field, the water or other aqueous liquid is referred to as "activated". As such "activated water" and "activated liquid" as used throughout this disclosure describe water or water-based solutions, such as saline solutions or cell culture solutions that have been subjected to this low-frequency, resonant electromagnetic field for at least <NUM> minutes.

Without being bound by theory, activation of water results in a modification of the clathrate structure. The structural changes to the clathrate have been studied in detail using electrochemical impedance spectroscopy (EIS). The activation of the water alters various physical and electrodynamic characteristics of the water. This activation optimizes its compatibility with the cell water, by forming a polarized-oriented multilayer molecular structure. As a result of this optimization, the activated water enters biological systems with easier bioavailability and faster assimilation. The activated liquid can then be used as a partial or complete substitute for non-activated liquid in numerous industrial chemical and biochemical reactions. TABLE <NUM> compares the properties of the activated water (MRET) compared to other water sources (reproduced from The Science of Healing Waters (Singapore: Times Books International, C2002), where ideal is a pH <NUM>-<NUM>; Redox <<NUM>; and Resistivity of <NUM>,<NUM>.

Turning now to <FIG> and <FIG>, what is disclosed is a large scale system <NUM> and method for the activation of liquids. By "large scale" it is meant that the system <NUM> is configured to activate thousands of gallons of water or water-based solutions in a single run or batch, such as <NUM> liters, <NUM> liters (<NUM> gallons, <NUM> gallons) or more. Liquid enters system <NUM> through water supply line <NUM>. Depending on the preferences of the user, liquid can be pumped into system <NUM> using a pump or can be drawn through piping by vacuum. Prior to delivery into activation tanks <NUM>, liquid is preferably pretreated using reverse osmosis system <NUM>, a liquid filter system, and/or a liquid purification system as known in the art to which the invention belongs to remove sediment and particulates from liquid supply. After which, pretreated liquid is optionally stored in storage tank <NUM> (here a <NUM> liters / <NUM> gal. storage tank <NUM> is shown) prior to delivering liquid to one or more activation tanks <NUM>, thereby increasing efficiency of the pretreatment step.

After optional pretreatment and storage steps, liquid is transferred to activation tank <NUM>. As storage tank <NUM> empties it can be refilled with pretreated liquid. Filling of activation tank <NUM> continues until tank full switch <NUM> is triggered, which closes valve (not shown) to stop inflow of liquid into activation tank <NUM>. As tank <NUM> fills, FILLING indicator <NUM> on control panel <NUM> can be illuminated to indicate status. Though described primarily with reference to a single tank <NUM>. The artisan will appreciate that two or more activation tanks <NUM> can be filled simultaneously or in series, however, in such embodiments, it is preferred that each activation tank <NUM> have dedicated switches <NUM>, <NUM>, thereby permitting each to be independently controlled. Though all may share a same control panel <NUM> and a same means for powering <NUM> the activation assembly <NUM> (e.g. power supply). Nonlimiting exemplary switches <NUM>,<NUM> include float switches and optical switches. As activation tank <NUM> fills, corresponding IN PROCESS indicator <NUM> can be illuminated on control panel <NUM>.

Once activation tank <NUM> is filled and full switch <NUM> triggered, activation of liquid can begin automatically by instructing operation of activation assembly <NUM> or can be held in a standby mode, waiting for timed activation program to instruct operation or waiting to receive manual operation instructions through control panel <NUM>, such as by pressing START button <NUM>.

Though primarily described with reference to the large scale system <NUM> for the activation of water or aqueous liquids, the activation assembly <NUM> can also be used with smaller scale activation of water or aqueous liquids. In instances where the volume of water to be activated is less than <NUM> liters (<NUM> gallons), the activation assembly <NUM> can be run for as little as <NUM> minutes, but it is generally preferred to run for <NUM> minutes or for <NUM> minutes.

Turning back to the large scale system <NUM>, once activation assembly <NUM> begins operation for the activation of liquids, COUNTDOWN window <NUM> on control panel <NUM> indicates time remaining for activation process and IN PROCESS indicator <NUM> is preferably illuminated. Activation time may vary depending on factors such as liquid volume. As generally guidance, activation of <NUM> liters (<NUM>,<NUM> gallons) of liquid generally takes between <NUM> and <NUM> hours but longer times can also be used. Activation timing is preferably determined and programmed into software of system <NUM>, however as an alternative, liquid can be tested using electrochemical impedance spectroscopy (EIS) as previously described in the literature.

Upon completion of liquid activation, activated liquid can be transferred into bottling system <NUM>, where activated liquid is bottled for desired uses. Once activation tank <NUM> is emptied or near emptied, tank empty switch <NUM> is activated, which instructs closing of emptying valve (not shown). Preferably, MEDIA LIFE indicator <NUM> is updated to display remaining life of media in activation assembly <NUM>. Life of media in activation assembly <NUM> is preferably preprogrammed into system <NUM>, such as by preprograming a number of activation cycles performed by system <NUM>. When MEDIA LIFE indicator <NUM> indicates servicing of activation assembly <NUM> is required or desirable, control panel <NUM> can notify user as such.

Turing now to activation assembly <NUM>, the system <NUM> preferably couples each activation tank <NUM> with a dedicated activation assembly <NUM> for activating liquid in each activation tank <NUM> independently. Activation assembly <NUM> is preferably joined to activation tank <NUM> above liquid fill level and preferably activates liquid in activation tank <NUM> through a port.

As shown more clearly in <FIG>, activation assembly <NUM> includes an elongated column <NUM> (e.g. approximately <NUM> (<NUM> inch) tall with a diameter of about <NUM> (<NUM>) inch) filled with a polymer composition (e.g. about <NUM>,<NUM><NUM> or in this instance <NUM>,<NUM><NUM>), which will be described in more detail in the passages that follow. Naturally, a larger or smaller activation assembly <NUM> could be used for larger or smaller activation tanks <NUM>. Bottom end of column <NUM> projects through top of activation tank <NUM> but preferably remains above fill line (defined by full switch <NUM>). A bobbin of copper wires <NUM> is wrapped around the column <NUM> to form a solenoid <NUM>. Preferably, the solenoid <NUM> includes <NUM>,<NUM> or about <NUM>,<NUM> windings of AWG-<NUM> copper wiring <NUM>. The top part of the solenoid <NUM> is open to a cluster of light emitting diodes (LEDs) <NUM>. Though non-limiting, the cluster of LEDS <NUM> can be a group of <NUM> yellow LEDs <NUM> or about <NUM> LEDs <NUM> mounted to a printed circuit board (PCB) suspending inches above column <NUM>. During activation, the LEDS <NUM> preferably oscillate at the same frequency as electric field.

Direct current is delivered to the solenoid <NUM> so that the solenoid <NUM> operates at 50v DC, 25mA and <NUM> kohms to produce a magnetic field of <NUM>,<NUM> - <NUM>,<NUM>,<NUM> A/m (<NUM>,<NUM>-<NUM>,<NUM> Oersteds). The field oscillates at a frequency of <NUM> Hertz (Hz) or about <NUM> (e.g. <NUM>-<NUM>). At the same time, PCB instructs the LED cluster <NUM> to oscillate at the same frequency. The polymer composition becomes energized and emits low frequency oscillations which causes the liquid to become and remain activated.

Turning now more specifically to the polymer composition, the polymer composition includes a polymer matrix in which the polymer has a linear chain length of at least <NUM> monomer units. Both thermosetting and thermoplastic polymers may be used. It is preferred to use polymers which possess comparatively high values of relative permittivity (dielectric constant), since that provides for easier displacement of both bonding and non-bonding electrons in these polymers by the external magnetic field and thus enhanced continuity with the electromagnetic and optical response of the incorporated materials. The polymers selected must, however, be capable of absorbing visible light radiation (v=<NUM>-<NUM>); absorption of optical (visible) radiation occurs in the polymers by irreversible non-radiative loss effects. Polymers which exhibit this capability include polyurethanes, epoxies, and furans. Polyurethane resins are well known polymers and are widely described in the literature. Typical descriptions can be found in <NPL>); <NPL>); and <NPL>). Similarly, epoxy polymers can be found described in many references, including the aforementioned <NPL>); <NPL>); and <NPL>). Also, furan (or furfuyl) polymers can be found described in many references, including the aforementioned <NPL>.

Incorporated throughout (i.e., impregnated or filled into) the polymer resin matrix, in finely divided form, are a number of different materials, all selected so that the polymeric activation body containing these materials when subjected to the <NUM>,<NUM> - <NUM>,<NUM>,<NUM> A/m (<NUM>,<NUM>-<NUM>,<NUM> Oersteds) magnetic field responds to the <NUM>-<NUM> frequencies and <NUM>-<NUM> wavelengths of the emitted light and resonates to produce electromagnetic oscillations of low frequency which enhance and intensify the normal coronal discharge of the incorporated materials within the polymeric matrix. The frequency of these resultant oscillations is generally in the range of <NUM>-<NUM>.

The incorporated materials are selected from several classes of compounds, of which at least two classes must be dispersed in the impregnated or filled polymer, in finely divided form, and at a concentration of from <NUM>-<NUM> parts by weight per <NUM> parts by weight of polymer, to form the activating polymer matrix. These classes of compounds are (a) metals and metal salts including metals, oxides, nitrates, sulfates or tartrates of Groups 1a, 3a, 4a, 5a, 5b, 6b and 8b elements, preferably aluminum, antimony, boron, chromium, iron, lead, nickel, niobium, osmium or potassium; (b) silicates and carbonates, such as those from the calcite family, quartz family and jade family, as well as from shells of marine organisms, which are primarily carbonates and silicates of elements such as calcium, copper, sodium and aluminum, as well as various forms of silica itself; (c) inorganic acids, preferably weaker inorganic acids (pH ≧<NUM>. preferably ≧<NUM>), such as boric acid (pH=<NUM>); (d) aminoaldehydes and pyridines, and (e) analgesics. In a particularly preferred embodiment, the incorporated materials include Chromium oxide (Cr<NUM>O<NUM>); Citric acid (C<NUM>H<NUM>O<NUM>); Agar powder; Manganese chloride (MnCl<NUM>); and Riboflavin (C<NUM>H<NUM>N<NUM>O<NUM>).

The above described system <NUM> was tested by filling each of two activation tanks <NUM> with reverse osmosis treated water, and powering each corresponding activation assembly <NUM>. Water was then tested using electrochemical impedance spectroscopy (EIS) as previously described in the literature. The EIS analysis confirmed that the water had been activated.

As will be described in more detail in the examples that follow, there are various benefits of providing activated water to various biological systems. In particular, activated water is shown to have antitumor effects, properties that reduce both brain plaque area and density and alter the cytotoxic activity of lymphocytes. The activated water is also shown to have the ability to control the growth of abnormally proliferating cells and E. Activated water is also shown to amplify the efficiency of some antibiotics and provide benefits in the treatment of psoriasis and other diseases. Activated water is also shown to inhibit or reduce viral infection (e.g. SARS-CoV) and bacterial infection (e.g. Staphylococcus). Examples of some of these applications are now discussed in more detail in the examples that follow.

Among the beneficial uses of activated water as disclosed herein is for reducing or inhibiting tumor cell proliferation. An exemplary use includes providing a subject suffering from or at risk of suffering from tumor growth; activating water or liquid by exposing the water or liquid to low frequency oscillations of <NUM> to <NUM>; and administering the activated water or liquid to the subject daily. The water or liquid is activated using an activation assembly that simultaneously applies an alternating electric current at a frequency between <NUM> to <NUM> and applies light at a wavelength between <NUM> and <NUM> to a polymer composition that in response produces the low frequency oscillations. Though activation times may vary, currently preferred activation times of the volumes tested range from <NUM> minutes to <NUM> minutes, more preferably with a time from <NUM>-<NUM> minutes and a most preferred activation time of <NUM> minutes.

The subject is preferably human but the activated water can also be used in veterinary medicine, such as for either domesticated or wild animals, including livestock.

Among the tumors that can be treated include those found in breast cancer, prostate cancer, renal cancer, intestinal cancer, malignant gliomas, osteosarcoma, malignant melanoma, pancreatic cancer, malignant lymphomas and esophageal cancer.

In some embodiments, the tumor to be treated is a sarcoma. Examples of soft sarcomas that may be treated to reduce or inhibit cancer cell proliferation include angiosarcoma, fibrosarcoma, a gastrointestinal stromal tumor, Kaposi's sarcoma, liposarcoma, leiomyosarcoma, malignant fibrous histiocytoma, neurofibrosarcoma, rhabdomyosarcoma and synovial sarcoma. Bone sarcomas, such as osteosarcoma, Ewing's sarcoma, and chondrosarcoma can also be treated.

In support of the above, the prophylactic and therapeutic use of activated water is demonstrated with respect to Ehrlich Ascites Carcinoma (Ehrlich cells, EAC). In particular, the prophylactic and therapeutic use of activated water increased tumor inhibition and increased lifespan in an accepted EAC model.

Ehrlich Ascites Carcinoma (Ehrlich cells, EAC), a spontaneous murine mammary adenocarcinoma, is a well-established model in tumor biology. EAC model has largely been used for studying tumor pathogenesis and development of anti-tumorigenic agents. See <NPL>); <NPL>). In this example the prophylactic and therapeutic antitumor effects of different fractions of molecular resonance effect technology-activated water were tested on the tumor model of Ehrlich ascitic carcinoma.

Procedurally, five different fractions of activated water were prepared to elucidate antitumor effects of activated water over different durations of activation. Four water fractions were activated for <NUM>, <NUM>, <NUM> or <NUM>. Also, a large volume of water was activated for <NUM> and stored at <NUM> for about <NUM> days. This water also was used in the study. This fraction of activated water was named as "old activated water". Investigations with "old activated water" were aimed to research the influence of activated water "aging" on antitumor and immunostimulatory effects in vitro and in vivo. Analogous control investigations using non-activated distilled water were also carried out.

Inbred adult male BALB/c mice at <NUM> weeks of age and having a corporal weight of <NUM> - <NUM> grams were used. BALB/c mice (genetic formula "bbcc", H-<NUM> a is the major histocompatibility complex allele) are white mice which are very susceptible to various oncogenous viruses.

In summary, <NUM> mice were assigned to either a prophylactic action group (<NUM> mice), a therapeutic action group (<NUM> mice), or a control group (<NUM> mice). The prophylactic action group was further split into <NUM> different prophylactic treatment regimens of <NUM> mice each (<NUM>*<NUM>=<NUM>). The prophylactic groups are also referred to as water fractions <NUM>-<NUM>. The prophylactic treatment regimen included feeding mice daily with the different MRET activated water fractions (<NUM>, <NUM>, <NUM>, <NUM>, old water) for up to fourteen days prior to inoculation. Mice where then inoculated intraperitoneally with <NUM>,<NUM> Ehrlich ascitic carcinoma (EAC) cells and the day after inoculation the same feeding regimen continued.

The therapeutic action group was split into <NUM> different therapeutic treatment regimens of <NUM> mice each (<NUM>*<NUM>=<NUM>). The therapeutic groups are referred to as Water Fractions <NUM>-<NUM>. The therapeutic treatment regimen included feeding all mice daily with non-activated water fractions for up to fourteen days prior to inoculation. Mice where then inoculated intraperitoneally with <NUM>,<NUM> Ehrlich ascitic carcinoma (EAC) cells. The day after inoculation, the treatment regimen included feeding mice daily with the different MRET activated water fractions (<NUM>, <NUM>, <NUM>, <NUM>, old water).

Control group (also referred to as Water Fraction <NUM>), included <NUM> mice that were fed nonactivated water for up to fourteen days prior to inoculation. Mice where then inoculated intraperitoneally with <NUM>,<NUM> Ehrlich ascitic carcinoma (EAC) cells. After inoculation the mice were again fed nonactivated water daily.

The first stage was performed on day <NUM> after tumor cell inoculation for each group (prophylactic, therapeutic, control), where <NUM> mice from each treatment regimen were sacrificed and ascitic fluids containing tumor cells were obtained from peritoneal cavities. During the second stage, the remaining <NUM> mice from each treatment continued post-inoculation treatment and were monitored for survival.

Exemplary results are depicted in <FIG>, which shows that the volume of ascitic fluid obtained from peritoneal cavities of mice at day <NUM> after inoculation that underwent prophylactic treatment with water activated for <NUM> (left <NUM> samples) was significantly less (about one-half) than the volume obtained from control (right <NUM> samples). Each tube contains ascitic fluid obtained from one mouse.

<FIG> provides a table comparing the efficacy of the different treatment regimens on the inhibition of tumor growth. As summarized in the table, average volume of ascitic fluid obtained per mouse (also referred to as one tumor) and average number of viable tumor cells per mL of ascitic fluid where measured to determine the average number of viable tumor cells in the peritoneal cavity of each mouse and thus to calculate percent of tumor growth inhibition. In summary, a positive antitumor effect was displayed by a decrease in both the volume of ascitic fluid in peritoneal cavity of tumor-bearing mice and the reduced content of viable tumor cells. Ascitic fluid volume was decreased approximately <NUM>-fold in animals under the prophylactic regimen group (t act = <NUM>) in comparison with control animals. Similar tendency and approximately the same efficacy were observed in other groups with prophylactic application of activated water (t act = <NUM>, <NUM> and <NUM>). In contrast the effect of activated water (t act = <NUM>) on tumor growth in mice of group "prophylactic treatment" was significantly weak (average ascitic fluid volume of each mouse from this group was <NUM> compared to <NUM> in control - increasing by <NUM>%).

<FIG> is a graph grouping the average volume (V) of ascitic fluid obtained from control, prophylactic regimen (<NUM>-<NUM>), and the therapeutic regimen (<NUM>-<NUM>) according to water activation time. <FIG> is a graph grouping the average number of viable tumor cells (C) obtained from control, prophylactic regimen (<NUM>-<NUM>), and the therapeutic regimen (<NUM>-<NUM>) according to water activation time on day <NUM>. Likewise, <FIG> is a graph grouping the average number of viable tumor cells per mL of ascitic fluid (C/V) obtained from control, prophylactic regimen (<NUM>-<NUM>), and the therapeutic regimen (<NUM>-<NUM>) according to water activation time on day <NUM>. In all instances, activated water slowed tumor proliferation. The greatest slowing of tumor proliferation was found using the prophylactic treatment approach, which suggests the regular ingestion of activated liquids may slow or prevent tumor progression in subjects.

<FIG> is a photograph of exemplary mice on day <NUM> after EAC inoculation comparing (A) the control group and (B) the prophylactic treatment groups (t= <NUM>). The photograph clearly shows the build up of ascitic fluid in the control.

<FIG> is a photograph showing side by side the mice from prophylactic treatment groups that received water activated for <NUM>. Mice treated with freshly activated water are placed on the left side of the photo, whereas mice that received "old activated water" - on the right side. Photo was making on the 19th day after mice were inoculated with cells of ascitic Ehrlich carcinoma.

<FIG> is a photograph on day <NUM> after inoculation showing the EAC inoculation was lethal to the entire control group (left side), while some mice from the prophylactic treatment group (t= <NUM>) survived. This again supports the regular ingestion of activated liquids to slow or prevent tumor progression in subjects.

<FIG> is a table showing results, where an increase in the average lifespan (mean) and median lifespan within the prophylactic and therapeutic treatment groups was found compared to control. Also shown is the percentage increase in lifespan for each treatment group compared to control.

<FIG> is a graph showing the survival rate over time of mice under the prophylactic treatment regimen for each of t=<NUM>, t=<NUM>, t-<NUM>, t=<NUM> and t=<NUM> (old activated water) compared to control. Each group significantly outlived control.

<FIG> is a graph showing the survival rate over time of mice under the therapeutic treatment regimen for each of t=<NUM>, t=<NUM>, t=<NUM>, t=<NUM> and t=<NUM> (old activated water) compared to control. Each group significantly outlived control.

<FIG> is a graph demonstrating the percentage increase in life span of each group of the prophylactic and therapeutically treated mice.

In summary, results show that activated water was able to substantially inhibit or reduce tumor growth in mice with transplanted ascitic Ehrlich carcinoma.

It is important to note that although long-term storage of activated water decreased its antitumor activity compared to freshly treated water under the same time (e.g. <NUM>), it did not abrogate it. Thus, while activated long term water is useful as an antitumor substance, freshly treated water having an exposure time of <NUM> showed the best results. For completeness, the tumor inhibition index of mice receiving "old activated water" (t act = <NUM>) in the prophylactic treatment group was approximately <NUM>%. It was substantially better as compared to mice from the prophylactic treatment group receiving freshly activated water, where activation was form <NUM>. In the case of the latter, percentage increase in life span was <NUM>%.

Results clearly show the potent effect of activated water on total tumor cell counts. In particular, total tumor cell counts in mice from the prophylactic treatment group which received water activated in the most optimal regimen (t act = <NUM>) was <NUM>-fold decreased compared to control mice.

Solely a therapeutic application of activated water was less effective than corresponding prophylactic treatment regimens. Solely therapeutic approaches resulted in tumor growth inhibition indices between about <NUM>-<NUM>%; whereas, most prophylactic treatment regimens were well above <NUM> %, reaching over <NUM>% to about <NUM>%. Application of water activated during <NUM> was the most effective.

It can also be concluded that the use of activated water has a substantial influence on the survival of tumor-bearing animals. When activated water was applied in "prophylactic treatment" regimens, the increase in life span was observed in all groups of mice. Water activated during <NUM> had the most potent effect on survival. It has been shown that average survival time of mice which received water (t act = <NUM>) in "prophylactic treatment" regimen increased to <NUM>%. Very marked increase in life span (about <NUM>%) was observed when mice were treated with activated water in "prophylactic treatment" regimen at t act = <NUM> and t act = <NUM>.

When mice received activated water in "therapeutic treatment" regimen, significant positive effects on increase in lifespan were also observed. However, values of estimated index were <NUM>-<NUM>% lower than in "prophylactic treatment" regimens. It can be suggested that water activated during <NUM> might not be effective under solely therapeutic applications.

Furthermore, application of such water aimed on tumor growth prophylaxis did not have any adverse effects that are typical for chemotherapy of cancer.

In another exemplary study, the prophylactic and therapeutic antitumor effects of different fractions of molecular resonance effect technology-activated water was tested on an ascitic sarcoma tumor model, which is a commonly used model for tumors with connective tissue histogenetic origin.

Five different fractions of activated water were prepared to elucidate antitumor effects of activated water depending on time of its activation. Four water fractions were obtained after water activation during <NUM>, <NUM>, <NUM> and <NUM>. Also, a large volume of water was activated during <NUM> and stored at <NUM>° C about <NUM> days. This water also was used in the study. This fraction of activated water was named as "old activated water". Investigations with "old activated water" were aimed to research the influence of activated water "aging" on its antitumor and immunostimulatory effects in vitro and in vivo. Analogous control investigations using non-activated distilled water were carried out.

Inbred adult male BALB/c mice at <NUM> weeks of age, with <NUM> - <NUM> corporal weight were used. BALB/c mice (genetic formula "bbcc", H-<NUM> a is the major histocompatibility complex allele) are white mice which are very susceptible to various oncogenous viruses.

Similar to the above, <NUM> mice were assigned to either a prophylactic action group (<NUM> mice), a therapeutic action group (<NUM> mice), or a control group (<NUM> mice).

The prophylactic action group was further split into <NUM> different prophylactic treatment regimens of <NUM> mice each (<NUM>*<NUM>=<NUM>). The prophylactic groups are also referred to as water fractions <NUM>-<NUM>. The prophylactic treatment regimen included feeding mice daily with the different MRET activated water fractions (<NUM>, <NUM>, <NUM>, <NUM>, old water) for up to fourteen days prior to inoculation. Mice where then inoculated intraperitoneally with <NUM>,<NUM> viable ascitic sarcoma tumor cells and the day after inoculation, the same feeding regimen continued for <NUM> days.

The therapeutic action group was further split into <NUM> different therapeutic treatment regimens of <NUM> mice each (<NUM>*<NUM>=<NUM>). The therapeutic groups are referred to as Water Fractions <NUM>-<NUM>. The therapeutic treatment regimen included feeding all mice daily with non-activated water fractions for up to fourteen days prior to inoculation. Mice where then inoculated intraperitoneally with <NUM>,<NUM> viable ascitic sarcoma tumor cells. The day after inoculation, the treatment regimen included feeding mice daily with the different MRET activated water fractions (<NUM>, <NUM>, <NUM>, <NUM>, old water).

Control group (also referred to as Water Fraction <NUM>), included <NUM> mice that were fed nonactivated water for up to fourteen days prior to inoculation. Mice where then inoculated intraperitoneally with <NUM>,<NUM> viable ascitic sarcoma tumor cells. After inoculation the mice were again fed non-activated water daily.

The first stage was completed on the 8th day after tumor cell inoculation for each group (prophylactic, therapeutic, control), where <NUM> mice from each treatment regimen were sacrificed and ascitic fluids containing tumor cells were obtained from peritoneal cavities. During the second stage, the remaining <NUM> mice from each treatment continued post-inoculation treatment and were monitored for survival.

Exemplary results are depicted in <FIG>, which shows the volume of ascitic fluid obtained from peritoneal cavities of mice at day <NUM> after inoculation that underwent prophylactic treatment with water activated for <NUM> (right <NUM> samples) was significantly less than the volume obtained from control (left <NUM> samples).

Additional results are shown in <FIG>, which shows the volume of ascitic fluid obtained from peritoneal cavities of mice at day <NUM> after inoculation that underwent prophylactic treatment with water activated for <NUM> (left <NUM> samples) was significantly less than the volume obtained from control (right <NUM> samples).

<FIG> is a table comparing the efficacy of the different treatment regimens on inhibition of tumor growth. As summarized in the table, average volume of ascitic fluid obtained per mouse (also referred to as one tumor) and average number of viable tumor cells per mL of ascitic fluid where measured to determine the average number of viable tumor cells in the peritoneal cavity of each mouse and thus the percent of tumor growth inhibition.

In summary, treatment with activated water resulted in an inhibitory effect on the growth of transplanted sarcoma <NUM> tumor cells in mice; though, such effects were less marked compared to the Ehrlich ascitic carcinoma (EAC) model. In particular, treatment with activated water resulted in reduced volume of ascitic fluid from the peritoneal cavity and fewer tumor cells compared to control. Optimal results were achieved using water activated for <NUM> minutes under the prophylactic regimen, which inhibited tumor growth of sarcoma <NUM> by <NUM> %, which was surprising. For completeness, use of water activated for <NUM> and <NUM> in the prophylactic regimen inhibited tumor growth <NUM>% and <NUM> % respectively, which is similar to the results achieved when using water activated for <NUM> in the prophylactic approach.

<FIG> is a graph grouping the average volume (V) of ascitic fluid obtained from control, prophylactic regimen (<NUM>-<NUM>), and the therapeutic regimen (<NUM>-<NUM>) according to water activation time. <FIG> is a graph grouping the average number of viable tumor cells (C) obtained from control, prophylactic regimen (<NUM>-<NUM>), and the therapeutic regimen (<NUM>-<NUM>) according to water activation time on day <NUM>. <FIG> is a graph grouping the average number of viable tumor cells per mL of ascitic fluid (C/V) obtained from control, prophylactic regimen (<NUM>-<NUM>), and the therapeutic regimen (<NUM>-<NUM>) according to water activation time on day <NUM>.

<FIG> is a photograph of mice on day <NUM> after inoculation with ascitic sarcoma <NUM> comparing the prophylactic treatment group (t= <NUM>) on the left and the control group on the right. <FIG> is a photograph taken <NUM> days after tumor cell inoculation, showing side by side the mice from the prophylactic treatment group that received water activated for <NUM> (left side) compared to mice from the therapeutic treatment group that also received water activated for <NUM>.

<FIG> is a table showing the difference in the average lifespan (mean and median) within the prophylactic and therapeutic treatment groups compared to control. Also shown is the percentage change in lifespan for each treatment group compared to control. Overall, the "therapeutic treatment" regimen of activated water application was less effective than the "prophylactic treatment" regimen. In furtherance of this, water activated for <NUM> under the therapeutic regimen resulted in an insignificant effect on lifespan.

<FIG> is a graph showing the survival rate over time of mice under the prophylactic treatment regimen for each of t=<NUM>, t=<NUM>, t-<NUM>, t=<NUM> and t=<NUM> (old activated water) compared to control. All groups clearly outlived control.

<FIG> is a graph showing the survival rate over time of mice under the therapeutic treatment regimen for each of t=<NUM>, t=<NUM>, t=<NUM>, t=<NUM> and t=<NUM> (old activated water) compared to control. Though less impressive as the prophylactic treatment group, the therapeutic treatment group statistically outlived control.

<FIG> is a graph summarizing the percentage increase in life span of each group of the prophylactic and therapeutically treated mice for the different treatment regimens.

Like in the EAC model, use of activated water increased the lifespan of mice after transplanting sarcoma <NUM> tumor cells. Similar to the EAC model, the greatest increase in lifespan was observed when mice received water activated for <NUM> in the "prophylactic treatment" regimen. The increase in lifespan was <NUM> %. When mice were treated with water activated during <NUM> and <NUM> the increases in lifespan were quite similar, approximately <NUM>-<NUM> %.

Importantly, results show that tumor growth was reduced, and lifespan was extended, even when mice received "old activated water" (activation time was <NUM> minutes). Further, in each of the prophylactic and therapeutic regimens, increase in lifespan was about the same between the "old activated water" (at <NUM>) and water activated for <NUM>.

In conclusion it can be noted that prophylactic application of optimally activated water resulted in significant tumor growth inhibition within the sarcoma <NUM> model. Lifespan was increased over <NUM>%. While the therapeutic treatment regimen also increased lifespan generally, it was less successful than the prophylactic approach. Furthermore, long-term storage of activated water did not cause significant decrease of antitumor efficacy and thus activated water that is stored long term can be used as a treatment or preventative approach against sarcoma and likely other cancers.

Also disclosed is use of the activated water for enhancing NK cell killing of tumor cells. An exemplary method includes exposing NK cells to the activated water or liquid, where the water or liquid is activated by exposing the water or liquid to low frequency oscillations of <NUM> to <NUM> from an activation assembly that simultaneously applies an alternating electric current at a frequency between <NUM> to <NUM> and applies light at a wavelength between <NUM> and <NUM> to a same polymer compositing that in response produces the low frequency oscillations; and exposing the NK cells to tumor cells.

The subject is preferably human but can also be used in veterinary medicine, such as for either domesticated or wild animals, including livestock.

Among the cancer cells that can be targeted by the NK cells are those found in breast cancer, prostate cancer, renal cancer, intestinal cancer, malignant gliomas, osteosarcoma, malignant melanoma, pancreatic cancer, malignant lymphomas and esophageal cancer.

In some embodiments, the cancer cell is a sarcoma. Examples of soft sarcomas that may be treated to reduce or inhibit cancer cell proliferation include angiosarcoma, fibrosarcoma, a gastrointestinal stromal tumor, Kaposi's sarcoma, liposarcoma, leiomyosarcoma, malignant fibrous histiocytoma, neurofibrosarcoma, rhabdomyosarcoma and synovial sarcoma. Bone sarcomas, such as osteosarcoma, Ewing's sarcoma, and chondrosarcoma can also be treated.

In support of the above, the prophylactic and therapeutic use of activated water is demonstrated with respect to improving NK cell cytotoxic activity against tumor cells.

In this example changes in cytotoxic activity of lymphocytes within mice treated with different fractions of molecular resonance effect technology-activated water, are demonstrated.

In order to understand the possible mechanism of antitumor effects of activated water the studies of changes in cytotoxic activity of lymphocytes of mice treated with different fractions of activated water were carried out. Natural killer (NK) cells are an important part of the immune system. Based on their defining function of spontaneous cytotoxicity without prior immunization, NK cells have been thought to play a critical role in immune surveillance and cancer therapy. NK cells that infiltrate tumors may protect against tumor spread. A second major role of NK cells is their productions of cytokines, which may be critically important to eliminate infections. Now active search and screening of substances with potent immunostimulatory activity are carried out.

Augmentation of NK cell activity caused by different modifying substances of natural origin has been a large interest with respect to correction of NK cell functional activity in various pathological states and neoplastic malignancies especially. Results of investing the effects of different activated water fractions on NK cell activity are presented below. The study was aimed to evaluate optimal regimens of water activation and regimen of activated water application for maximal stimulation of NK cell cytotoxic activity.

In summary, five different fractions of activated water were prepared to elucidate effectiveness of antitumor effects of activated water depending on time of its activation. Four water fractions were obtained after water activation during <NUM>, <NUM>, <NUM> and <NUM>. Moreover, before beginning of investigations a large volume of water was activated during <NUM> and stored at <NUM> C° for about <NUM> days. This water also was used in the study. This fraction of activated water was named as "old activated water". Investigations with "old activated water" were aimed to research the influence of activated water "aging" on its antitumor and immunostimulatory effects in vitro and in vivo. Analogous control investigations using non-activated distilled water were carried out.

Under the "prophylactic treatment" regimen, the five groups of mice (t=<NUM>, t=<NUM>, t=<NUM>, and t=<NUM>, "old water") were fed the activated water over <NUM> days. Under the "therapeutic treatment" regimen, five groups of mice were fed nonactivated water for <NUM> days then the different fractions of activated water (t=<NUM>, t=<NUM>, t=<NUM>, and t=<NUM>, "old water") for <NUM> days. Under the "control regimen" one group of mice was fed nonactivated water over the entire <NUM> days. Water activation was performed just prior to feeding in "fresh water" instances.

The lymphocyte fraction enriched with natural killer cells (NKC, NK cells) was isolated from spleens from all groups of mice. More specifically, splenocytes were obtained by the homogenization of spleens resected from mice in Potter's homogenizer to obtain single cell suspension and passed through a nylon mesh filter for clumps removal. Mononuclear lymphocytes were isolated by a standard Ficoll-Verografin technique. The final concentration of lymphocytes was <NUM> × <NUM><NUM> cells/ml. As a result, the lymphocyte fraction enriched with NK cells (about <NUM>-<NUM>%) was obtained.

Ascitic Ehrlich carcinoma cells were isolated from peritoneal cavity of white mice at <NUM>-<NUM> weeks of age on the 8th day after tumor cell inoculation and were used in cytotoxic test as NK-resistant target cells (TC). Tumor cells were suspended in cultivation medium to concentration <NUM>×<NUM><NUM> cells/ml and their number and viability were determined in microscopical supravital test with trypan blue. Cell viability was about <NUM>%.

All cytotoxicity tests were performed in <NUM>-microwell round-bottomed plates using target - effector cell ratio of <NUM>:<NUM> in a total volume <NUM>µl/well. In controls, only TC and nutrient medium or TC and lymphocytes obtained from "control" group mice were added. In experimental wells <NUM> of TC and <NUM> of lymphocytes isolated from spleens of mice treated with different types of activated water were added.

Mononuclear lymphocytes obtained from each experimental mouse were placed into three wells of plate. So, effect of each fraction of activated water (and nonactivated control water too) on cytotoxic activity of NK cells was evaluated in <NUM> independent experiments and was considered as significant.

Similarly, <NUM> independent experiments were performed when only <NUM> of TC suspension and <NUM> of nutrient medium were added into one well. Those experiments allowed to determine the average "basal" number of dead tumor target cells Ntc that could not be caused by cytotoxic influence of effector cells. The "basal" number of dead tumor target cells was "reference point" for evaluation of cytotoxic activity of NK cells obtained from mice after different types of activated water application.

After incubation at <NUM> for <NUM> hours in humidified atmosphere with <NUM>% CO<NUM>, microplates were gently centrifuged (<NUM>×g, <NUM>).

The numbers of viable and dead TC in control and experimental wells were determined using microscopical test with supravital staining with trypan blue.

Cytotoxic activity of NK cells was expressed as cytotoxicity index (CI, %) and was calculated as follows:
<MAT>.

Based on this definition CI for "basal" experiments equal zero.

In addition to comparing the activity of lymphocytes obtained from mice treated with activated water the investigation of immunostimulatory action of reference chemical agent that belongs to phorbol ether family was also applied. Phorbol myristate acetate (PMA; chemical formula: <NUM>-O-tetradecanoylphorbol-<NUM>-acetate) in concentration <NUM> ng/ml was used as standard stimulant of lymphoidmacrophage lines.

<FIG> summarizes the effects of activated water on cytotoxic activity of splenic mononuclear lymphocytes with NK-activity. In particular, the average number of viable tumor cells (TC) for each group as well as they cytotoxicity index (CI%) and change in cytotoxicity index (in relation to nonactivated water) as a percent is shown.

<FIG> is a graph summarizing the results of activated water feeding on cytotoxic activity of lymphocytes with natural killer cell activity. Both prophylactic (<NUM>-<NUM>) and therapeutic (<NUM>-<NUM>) regimens are shown compared to control. TPA was used as a reference stimulant of lymphoid cells.

<FIG> is a graph summarizing results from the cytotoxic index change from <FIG> comparing cytotoxic activity of mononuclear lymphocytes from mice receiving different types of activated water in comparison to results of non-activated water application. The x-axis provides duration of water activation expressed in minutes for the prophylactic group and the therapeutic treatment groups. The greatest change was found in the prophylactic group, where water was activated for <NUM> minutes.

The results demonstrate that the immunostimulatory potential of activated water is dependent on both duration of activation and duration of storage of activated water before treatment of mice. Further, the results show that changes in cytotoxic activity of NK cells in mice was prolonged.

In particular, when water that was activated for <NUM> minutes was applied in a prophylactic regimen a significant increase in cytotoxic activity of lymphocytes was observed. Additionally, the application of this activated water in the prophylactic treatment regimen was shown to result in an increase of the cytotoxicity index by <NUM>% as compared to control values. The control values were obtained by application of non-activated water.

The analysis of cytotoxic activity based on the duration of applying activated water showed the efficacy of the prophylactic application of the water was increased when the treatment period with activated water was prolonged or increased.

The therapeutic treatment regimen of activated water application, which had an activation time of <NUM> minutes, resulted in an insignificant increase of natural cytotoxicity levels. The group did not exceed <NUM>%. Similar immunostimulatory effect of "prophylactic treatment" regimen of "old activate water" application, which had an activation time of <NUM> minutes, was observed. The data suggests that therapeutic application of water activated during <NUM> and <NUM> resulted in modest potentiation of NK cell cytotoxic activity. However, prolonged feeding of <NUM> days ("therapeutic treatment" regimen) to <NUM> days ("prophylactic treatment" regimen) normalized the values of cytotoxicity index which were equal to control data. Application of other fractions of activated water did not cause statistically significant changes of NK cell cytotoxic activity.

Thus, significant increase of lymphocyte cytotoxicity levels was observed only when mice were treated with water activated for <NUM> minutes. It must be noted that immunostimulatory potential of activated water was less marked than the same observed after in vitro stimulation of lymphocytes with PMA. CI values of PMA-stimulated NK cells were increased in <NUM>%, whereas activated water application resulted in only <NUM>% of natural cytotoxicity potentiation. However, augmentation of NK cell activity caused by activated water application is quite promising approach for non-drug stimulation of immunity.

In conclusion, feeding activated water can induce significant activation of NK cell cytotoxic potential. In this scenario, it is apparent that application of activated water in tumor-bearing immunocompetent hosts would result in cytotoxic activation of NK cells to destroy tumor cells. Thus, these obtained results are important for therapeutic approaches involving activated water.

Also disclosed is use of the activate water for preventing or reducing amyloid plaques. An exemplary method includes: providing a subject suffering from or at risk of suffering from the formation of amyloid plaques; activating water or liquid by exposing the water or liquid to low frequency oscillations of <NUM> to <NUM> from an activation assembly that simultaneously applies an alternating electric current at a frequency between <NUM> to <NUM> and applies light at a wavelength between <NUM> and <NUM> to a polymer composition that in response produces the low frequency oscillations; and administering the activated water or liquid to the subject daily.

Amyloid is a general term for protein fragments that the body produces normally. Beta amyloid is a protein fragment snipped from an amyloid precursor protein (APP). In a healthy brain, these protein fragments are broken down and eliminated. Amyloid plaques are hard, insoluble accumulations of beta amyloid proteins that clump together between the nerve cells (neurons) in the brains of Alzheimer's disease patients.

The subject is preferably human but can also be used in veterinary medicine, such as for either domesticated or wild animals, including livestock. In some embodiments, the human is elderly, such as over the age of <NUM>. In some embodiments, the human has or is at risk of developing Alzheimer's disease.

In support of the above, the activated water is demonstrated to increase brain matter and extend the lifespan in a transgenic amyloid animal model.

In this example the effects of activated water on the development of brain matter and mortality rate of mice is shown. Transgenic mice (TgCRND8-amyloid disease model) that were three weeks in age were fed either activated water or non-activated water for four months. In particular, <NUM> of the mice were given activated water and six were given non-activated water.

The activated water was generated using Millipore water and placing it in a range of the emittance of low frequency oscillations. The water was activated for <NUM> minutes then stored in sterile glass bottles. Non-activated water was untreated Millipore water that was filtered through a <NUM> micrometers (µm) filter.

The mice were provided both activated and non-activated water using conical tubes as water bottles. In the cases where wet feed was required, it was made in a plastic drug dose cup using both activated and non-activated water and a wooden stir stick. Both groups of water were restrained from interacting or contacting any metal.

After four months of providing animals either activated water or non-activated water, the animals were perfused with PBS during which the tail and brain were taken. Both the brain plaque density and mortality rates of the mice were recorded.

One hemisphere of each brain was post fixed, serially sectioned, stained for amyloid plaques (Amyloid monoclonal antibody as previously described; Janus et al. , <NUM>, McLaurin et al. , <NUM>) and number of plaques were counted visually. Plaque density and area covered by the brain were similar to observations as previously described (Janus et al. , <NUM>, McLaurin et al. The plaques were not counted in the brains of dead animals in either group. Nor was dead animal data used for statistical calculations. Half of the brains were placed at -<NUM> to allow further investigation. The mean value of total brain area for mice on activated water was by <NUM>% higher comparing with the mean value of total brain area for mice on non-activated water. <FIG> provides a chart demonstrating this data.

The typical mortality rate for the transgenic amyloid mice model is <NUM>-<NUM>%. During the course of the investigation, the mortality rate of the activated water group was limited to <NUM>% and the mortality rate of the non-activated water group was <NUM>%. <FIG> provides a chart demonstrating this data.

Also disclosed is use of the activated water for preventing or ameliorating effects of a skin disorder. An exemplary method includes: providing a subject suffering from or at risk of suffering from the skin disorder; activating water or liquid by exposing the water or liquid to low frequency oscillations of <NUM> to <NUM> from an activation assembly that simultaneously applies an alternating electric current at a frequency between <NUM> to <NUM> and applies light at a wavelength between <NUM> and <NUM> to a polymer composition that in response produces the low frequency oscillations; and administering the activated water or liquid to the subject daily. Examples include but are not limited to psoriasis, skin lesions, acne, atopic dermatitis, and ichthyosis.

The subject is preferably human but can also be used in veterinary medicine, such as for either domesticated or wild animals, including livestock. The compositions may be in the form of lotions, creams, ointments and gels, and also in the form of sprayable aerosols. Preferred formulations of the compositions according to the invention are creams, which may further contain saturated or unsaturated fatty acids such as stearic acid, palmitic acid, oleic acid, palmito-oleic acid, cetyl or oleyl alcohols, stearic acid being particularly preferred. Creams of the invention may also contain a non-ionic surfactant, typically polyoxy-<NUM>-stearate. In some embodiments, the activated water or liquid may be administered topically.

In support of the above, activated media is demonstrated to inhibit growth of callus cells, which provides a model for psoriasis. Callus tissue formation was carried out on segments of stalk from Solanum rickii in sterile cultural medium. Callus cells are mutated cells of botanical origin with the ability to produce uncontrolled, unlimited growth in nutrient medium. Accordingly, sterile agar-like cultural Murashige-Skoog medium with initiators for accelerating cell-like divisions of plants were added to the stalk segments. Media was either not activated (control), activated for <NUM> minutes, or activated for <NUM> minutes. Callus growth was monitored visually and ultimately by weighing.

Media activated for <NUM> minutes inhibited callus cell growth at a rate of <NUM> times compared with a control sample. Media activated for <NUM> minutes inhibited callus cell growth at a rate of <NUM> times compared to control. This demonstrates that a very strong suppression of callus cell growth when treated with water activation for <NUM> minutes. This also demonstrates that with a high probability that activated water is an effective agent for treatment of psoriasis and other diseases. <FIG> and <FIG> are photographs showing the first experiment, where <FIG> shows the callus cells prior to beginning the experiment and <FIG> shows results at a later time. The experiment was repeated and confirming results are shown in <FIG> and <FIG>.

<FIG> provides the initial average weight of one segment (in mg) before and after culturing in the presence of activated media (t= <NUM>, t=<NUM>) compared to control. Also shown is the corresponding increase in weight and the coefficient of inhibition of callus tissue growth for each group. <FIG>, column <NUM> represents the average increase of single segment weight of tissue in milligrams when placed in an activated medium for <NUM> minutes with a dilution ratio of <NUM>:<NUM>. Column <NUM> represents the average increase of single segment weight of tissue in milligrams when placed in an activated medium for <NUM> minutes with a dilution ratio of <NUM>:<NUM>. Column <NUM> of represents the average increase of single segment weight of tissue in milligrams when placed in a control sample such as distilled water.

In summary, strong growth inhibition of callus cells (Solanum rickii) was observed in activated media. Since the callus cell model data shows inhibition of callus cell growth, it is also expected that activated water can be used as a treatment for psoriasis.

Also disclosed is a method of reducing or inhibiting microbial growth, the method comprising applying to a surface at risk of microbial growth, a composition comprising activated water or activated liquid, wherein the activated water or liquid is produced by exposing the water or liquid to low frequency oscillations of <NUM> to <NUM> from an activation assembly that simultaneously applies an alternating electric current at a frequency between <NUM> to <NUM> and applies light at a wavelength between <NUM> and <NUM> to a polymer composition that in response produces the low frequency oscillations.

The activated water or liquid can be used in either bactericidal (those that kill bacteria) or in bacteriostatic (those that inhibit growth of cells). The water or liquid can be delivered in any suitable form such as liquid, gel, spray and thus may be formulated according to required or desired characteristics such as viscosity for intended application.

In support of the above, activated media is shown to have a significant effect on the growth of Escherichia coli (E. coli) in a beef-extract agar in an aerobic environment. During the investigation, the growth effect on E. coli bacteria was observed over <NUM> hours.

Two samples of water-based agar medium were activated consistent using of low frequency oscillations for <NUM> minutes and <NUM> minutes. The activated water was kept in a sterile environment for <NUM> hours. Afterwards, the E. coli bacteria was introduced to one sample of nonactivated water and two samples of activated water. Visual growth of E. coli bacteria began on the 17th hour of investigation.

<FIG> provides photographs showing results on the 23rd hour of the investigation. These photographs show a significant inhibition of the growth of E. coli in the activated water samples as compared to the nonactivated water.

<FIG> provides a summary graph showing results after <NUM> hours and <NUM> hours of investigation. The left columns of each chart represent the control sample. The middle columns of each chart represent the results from <NUM> minutes of water activation. The far-right column of each chart represents results from <NUM> minutes of water activation.

The data shows activation of water-based media has suppressed growth of E. coli bacteria at rates varying from <NUM> to <NUM> times. The inhibition of E. coli growth is more effective when activation time is increased. Water activated at an optimum regimen completely suppresses the growth of culture Escherichia coli in an aerobic environment.

As such, the activation of water using emit low frequency oscillations and other forms of molecular resonance effect technology provide a strong inhibition effect on bacteria growth.

Also disclosed is a method of enhancing the effects of an antibiotic. An exemplary method includes providing a surface at risk of microbial growth; and administering to the surface, an antibiotic in combination with activated water or an activated liquid. The activated water or activated liquid is produced by exposing the water or liquid to low frequency oscillations of <NUM> to <NUM> from an activation assembly that simultaneously applies an alternating electric current at a frequency between <NUM> to <NUM> and applies light at a wavelength between <NUM> and <NUM> to a polymer composition that in response produces the low frequency oscillations.

Exemplary combinations can be used in the packaging industry, food processing industry and anywhere at risk of microbial growth. Formulations can be used in medical and research laboratories. Formulations can be generated by activating the water or liquid then combining or coapplying the antibiotic. Exemplary antibiotics that can include Clindamycin, Kanamycin, Cephalexin, Cephtriaxon, Levomiticin, Ciphran, Ampicillin, Tetracykline, Cephaclor, and Karbenicyline.

In support of the above, activated media is demonstrated for its enhancing effect on antibiotics. In particular, effects of <NUM> different antibiotics on E. coli in activated water is shown.

Beef extract agar was formed using water activated for <NUM> minutes (<NUM>. 5hr), <NUM> minutes (<NUM> hr) or distilled water without activation as control (K). The following antibiotics were then plated (<NUM>) Clindamycin, (<NUM>) Kanamycin, (<NUM>) Cephalexin, (<NUM>) Cephtriaxon, (<NUM>) Levomiticin, (<NUM>) Ciphran, (<NUM>) Ampicillin, (<NUM>) Tetracykline, (<NUM>) Cephaclor, (<NUM>) Karbenicyline. The resistance to the effect of antibiotics (RA) was determined by the size (diameter) of the area of inhibition of bacteria growth.

<FIG> show the 16th hour of the investigation of this example. The maximal resistance to the effect of antibiotics was observed for <NUM> minutes activated samples. The minimal resistance to the effect of antibiotics was observed for <NUM> minutes activated samples.

<FIG> shows results after hour <NUM> of experimentation. The areas of the inhibition of bacteria growth significantly decreased by the end of this experiment. The maximal resistance to the effect of all antibiotics (the smallest diameter of area) was observed for <NUM> minutes activated samples. The minimal resistance to the effect of all antibiotics was observed for <NUM> minutes activated samples.

It was shown that both amplification of efficiency of activity of some antibiotics in <NUM>-<NUM> times on growth of microbiological culture and impairment of this activity in <NUM>-<NUM> times takes place. This effect depends on the duration of water activation. The directedness of change of activity of antibiotics and value of this change is different for different antibiotics.

The influence of activated water on the metabolic activity of microorganisms was assessed under both aerobic and anaerobic environments. Metabolic activity of E. coli in the presence of activated water was assessed by measuring the reducing activity of E. coli in distilled water (control), and water activated for <NUM> minutes or <NUM> minutes.

Resazurin reduction assays measure some aspect of general metabolism and act as a marker of viable cells. The assay includes incubating a reagent with a population of viable cells, which converts the substrate to a colored or fluorescent product that can be detected. Under most standard culture conditions, incubating of the substrate with viable cells will result in a signal that is proportional to the number of viable cells present. When cells die, they rapidly lose the ability to convert the substrate to product. In this instance, incubation was in the presence of distilled water (control), and water activated for <NUM> minutes or <NUM> minutes under both anaerobic and aerobic environments.

In regard to anaerobic environments, water activated for <NUM> minutes provided a significant increase in the reducing and enzyme activity of the E. More specifically, incubation with water activated for <NUM> minutes led to maximum reducing and enzyme activity (color transparent <NUM>%); incubation in water activated for <NUM> minutes led significant reducing and enzyme activity (<NUM>% transparent and <NUM>% colored); and incubation in distilled water that was not activated resulted in no reducing and enzymatic activity (<NUM>% colored).

In regard to aerobic environments, the reducing activity of E. coli was significantly inhibited.

Also disclosed is a method of protecting cells from damage from exposure to radiation. In support, the effects of activated water on human peripheral blood mononuclear cells (PMBC) and human astrocyte cells is demonstrated.

In this example, astrocytes are thawed, plated onto poly-lysine coated flasks and cultured for several days prior to seeding in flasks for irradiation. On the day before irradiation, cells were seeded in three poly-lysine T-<NUM> coated flasks. PMBCs were thawed and plated directly into three T-<NUM> flasks <NUM> hours prior to irradiation. Then three flasks of astrocytes and three flasks of PBMCs were irradiated. One flask from each cell type received no irradiation, one flask from each cell type received a radiation dose <NUM> Gy, and one flask from each cell type received a dose of <NUM> Gy. Cells were irradiated in a Gammacell model <NUM> extractor (MDS Nordion Gammacell).

Following irradiation, the cells from each flask were harvested, split in half, and resuspended in either normal untreated media (No MRET) or activated media (MRET). The cells were counted and plated at a density of <NUM>,<NUM> cells/well. The astrocyte cells were plated in poly-lysine coated <NUM> well plates while the PBMCs were plated into normal tissue culture treated <NUM> well plates. Each cell line was plate according to the plate map (<FIG>).

An MTT assay was performed at <NUM> hours and <NUM> hours using Cell Titer <NUM> Aqueous reagent (Promega) according to the manufacturer's recommendation. Half of the plates were assayed according to an MTT assay at <NUM> hours post-irradiation and the remaining half were assayed at <NUM> hours post irradiation. Plates were read on a <NUM> well plate reader (Molecular Devices Vmax kinetic microplate reader, molecular Devices LLC) at various time-points after addition of the MTT reagent. After collection of the study data, optical densities were plotted as a function of radioactive dose response curve for each cell line. Average OD values for replicate wells of each dose/treatment were plotted along with standard deviations. For each cell line, plates were read multiple times after addition of the MTT reagent. Optimal signals for the astrocytes were obtained after two hours of incubation.

<FIG> is a graph showing the effect of "activated" media (MRET) on astrocytes compared to control after <NUM> hrs. The average values of quadruplicate wells are plotted. Error bars represent standard deviations. <FIG> is a table showing the corresponding average values and standard deviation of quadruplicate wells.

<FIG> is a graph showing the effect of "activated" media (MRET) on astrocytes compared to control (no MRET) after <NUM> hrs. The average values of quadruplicate wells are plotted. Error bars represent standard deviations. <FIG> is a table showing the corresponding average values and standard deviation of quadruplicate wells.

For the astrocytes treated with normal media, little change in the MTT signal was observed in the <NUM> Gy treated wells compared to the untreated cells at both <NUM> and <NUM> hours post irradiation. However, the <NUM> Gy radiation dose resulted in a <NUM>% and <NUM>% drop in MTT signal at <NUM> hours and <NUM> hours respectively compared to the cells that received no radiation. When treated with MRET, little to no loss in MTT signal was observed in the <NUM> Gy treated wells at both <NUM> hour and <NUM> hours (<NUM>% increase and <NUM>% decrease respectively). Thus, the MRET treatment appears to protect the astrocytes against radiation induced damage.

<FIG> is a graph showing the effect of activated media (MRET) on PBMCs compared to control (no MRET) after <NUM> hrs. The average values of quadruplicate wells are plotted. Error bars represent standard deviations. <FIG> is a table showing the corresponding average values and standard deviation of quadruplicate wells.

<FIG> is a graph showing the effect of "activated" media (MRET) on PBMCs compared to control (no MRET) after <NUM> hrs. The average values of quadruplicate wells are plotted. Error bars represent standard deviations. <FIG> is a table showing the corresponding average values and standard deviation of quadruplicate wells.

For the PBMCs, little signal over that of the background media alone was observed. The most likely cause is the low cell numbers seeded into the wells. Increasing the number of PBMCs seeded in the wells may help resolve this. In addition, activation of the PBMCs with PHA to proliferate will also boost the signal if a low starting number of cells is required.

Also disclosed is the use of activated water for accelerating seed germination. An exemplary method includes activating water or liquid by exposing the water or liquid to low frequency oscillations of <NUM> to <NUM> from an activation assembly that simultaneously applies an alternating electric current at a frequency between <NUM> to <NUM> and applies light at a wavelength between <NUM> and <NUM> to a polymer activation body that in response produces the low frequency oscillations; and maintaining a plant seed under moist conditions through germination, where the moisture is from the activated water or liquid.

As a demonstration of the use of activated water or liquid to accelerate seed germination, the effect of activated water was assessed on seed germination for cabbage, pumpkin, string bean, garden radish and peas.

Seeds were germinated using distilled water activated for <NUM> minutes, <NUM> minutes or using regular non-activated water. After germination, watering continued as plants grew. Plants were then measured and averaged for height, stem weight and leaf area. Activated water was found to accelerate seed gemination. (data not shown). <FIG> shows that compared to control, watering with "activated" water increased average height, stem weight and leaf area with <NUM> minutes of activation providing the greatest increase.

<FIG> provides a series of photographs showing plants grown with water activated for <NUM> (left), water activated for <NUM> minutes (center) and regular water (right).

Also disclosed is use of activated water for reducing or inhibiting viral invasion of human cells, which includes: providing a subject having cells at risk of viral invasion; activating water or liquid by exposing the water or liquid to low frequency oscillations of <NUM> to <NUM> from an activation assembly that simultaneously applies an alternating electric current at a frequency between <NUM> to <NUM> and applies light at a wavelength between <NUM> and <NUM> to a polymer composition that in response produces the low frequency oscillations; and administering the activated water or liquid to the subject daily. In some embodiments, the virus is a severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

Previous research revealed that coronaviruses invade cells through so-called spike proteins. The spike protein is a surface protein used to bind to a cell receptor, which acts like a doorway into a human cell. After the spike protein binds to the human cell receptor, the viral membrane fuses with the human cell membrane, allowing the genome of the virus to enter human cells and begin infection.

The overall structure of <NUM>-nCoV S resembles that of SARS-CoV S, with a root mean square deviation (RMSD) of <NUM>Å over <NUM> Cα atoms. One of the larger differences between these two structures (although still relatively minor) is the position of the RBDs in their respective down conformations (<FIG>). Despite this observed conformational difference, when the individual structural. domains of <NUM>-nCoV S are aligned to their counterparts from SARS-CoV S, they reflect the high degree of structural homology between the two proteins.

The SARS-CoV-<NUM> spike protein has two key elements involved in infecting human cells. A string of amino acids in the S1 subunit directly binds to the protein-cleaving part of ACE2 called the peptidase domain. The S2 subunit of the spike protein helps the virus fuse to the human cell. Scientists have found that the protein-cleaving part of ACE2 binds the spike through polar interactions formed from a bridge-like structure on the enzyme. Both ends of the receptor binding domain stick to ACE2 through hydrogen bonding and van der Waals forces.

The stability of spike protein structure is based on the overall interactions of van der Walls weak electrodynamic forces and hydrogen bonding. The pre-fusion spike protein stability needs certain medium that supports required van der Walls interactions and hydrogen bonding to form the protein spike chain by coronavirus. It is obvious, that such medium is a water-based one, since all biochemical formations of proteins requires presence of water molecules in biological systems. The following transition of pre-fusion spike protein to post-fusion protein also requires specific water-based medium to support correct transition and formation of the bridges to help coronavirus fuse with the human cell membrane. The van der Waals forces among atoms and molecules generally act over relatively short distances, and are proportional to the inverse of the seventh power of the intermolecular distances for molecules and atoms. For two spheres of the same radius R, the interaction energy, W, as a function of the particle separation distance, D, is:
<MAT>
where the Hamaker constant, A<NUM>, depends on the relative dielectric constants of the material <NUM> and medium <NUM>.

Equation (<NUM>) yields for the significant role of the medium relative dielectric constant for the value of van der Waals interaction energy. It is seen from the equation the final character of the interaction between any bodies (molecules), its sign, and the intensity depend on the spectrum of the dielectric permittivity of these bodies and the water-salt medium in the region between them. The formation of any protein structures in the human body strictly depends on specific balance of dielectric property of protein molecules and water since it provides certain parameters of van der Walls forces to build such proteins. Dielectric property of water in its turn depends on temperature. We know from medicine that normal homeostasis of the human body is allowed at the precise physiological temperature parameters of the body: <NUM>° C - <NUM>° C on general basis. The drop of the body temperature below <NUM> as well as the rise of the body temperature above <NUM>° C leads to the inability to sustain life. There are research data indicating relation between dielectric constant of the human body tissue (TDC) and temperature: <NUM>° C - <NUM> F/m (TDC) and <NUM>° C - <NUM> F/m (TDC) (<FIG>). It shows that normal homeostasis of the human body is allowed at certain range of electrodynamic van der Walls interactions following the small range of tissue dielectric property about <NUM> - <NUM> F/m. It is well correlated since we know from physics that relative dielectric permittivity of water is <NUM> F/m at room temperature (<NUM>° C). It allows us to suggest that dielectric property of human body tissue is very important physiological parameter. For example, for the full band of frequencies analyzed, the dielectric constant of malignant colon tissue is on average <NUM>% higher than the dielectric constant of healthy one (p = <NUM>). This difference is even higher at frequencies below <NUM>.

Thus, normal healthy homeostasis of the human body directly depends on physiological temperatures and subsequently relative dielectric permittivity of the body liquids should be kept in the physiological range - a window of about <NUM> -<NUM> F/m. Any type of shifting from this range may lead to development of diseases including body infection with pathogenic microorganisms. Considering mentioned above ideas, it allows us to hypothesize that most of biochemical proteins building mechanisms in a healthy human body require certain physiological range window of van der Waals interactions and hydrogen bonding between proteins molecules and water - salt medium. In theory, this physiological window of van der Waals weak electromagnetic forces may be significantly different from the range of electrodynamic van der Waals interactions required for life sustains formation of DNA/RNA proteins of viruses. The same type of general mechanism can be adopted for other lines of bacteria and viruses as well. Thus, modification of water-based medium electrodynamic parameters can lead to significant change of van der Walls interactions and hydrogen bonding that may result in the inhibition and interruption of proper formation of spike proteins chains. Such scenario obviously disables corona-virus life sequence of attachment and fusion with human cell membranes. We suggest such agent which can interrupt coronavirus life sequence is MRET water with anomalous electrodynamic characteristics. MRET water can be consumed on the regular basis by human subjects to prevent coronavirus infection.

MRET Activated Water is produced with the help of patented in the USA Molecular Resonance Effect Technology (MRET, US Patent # <NUM>). MRET water activator is the stationary source of subtle, low-frequency, resonant electromagnetic field with composite structure. The origin of the low-frequency composite electromagnetic field is the intensive electrical activity inside the nano-circles formed by linear molecular groups of MRET polymer compound (volumetric fractal geometry matrix) when polymeric body is exposed to the external electromagnetic fields of specific frequency and wavelength. The significant reduction of values of electrical conductivity and dielectric permittivity confirms the relatively high, long-range dynamic structuring of water molecules in activated water produced with the help of MRET activation process. The long-term storage of activated water (up to <NUM> hours at <NUM>) did not significantly affect its modified electrodynamic characteristics, thus confirming the ability of MRET activated water to keep its anomalous properties for rather long period of time in case of <NUM> minutes activation, and even higher level of -long-term water memory phenomenon in case of <NUM> minutes activation. The significant level of reduction of dielectric permittivity and electrical conductivity kept by MRET water activated for <NUM> minutes after it was heated to <NUM> confirms its stability to thermal effects. It demonstrates the anomalous behavior of electrodynamic characteristics (dielectric permittivity and electrical conductivity) of MRET water subject to applied EMF (electromagnetic field) in the area of very low range of frequencies in order to provide some evidence regarding polarized-oriented multilayer structuring of MRET activated water and the possible effect of MRET water on the proper function of cells in biological systems.

Severe acute respiratory syndrome (SARS) is a febrile respiratory illness. The disease has been etiologically linked to a novel coronavirus that has been named the SARS-associated coronavirus (SARS-CoV), whose genome was recently sequenced. Since it is a member of the Corona-viridae, its spike protein (S2) is believed to play a central role in viral entry by facilitating fusion between the viral and host cell membranes. The protein responsible for viral-induced membrane fusion of HIV-<NUM> (gp41) differs in length and has no sequence homology with S2. Infection by many enveloped viruses requires fusion of the viral and cellular membranes. A viral envelope protein mediates this membrane fusion process. These proteins are synthesized as precursors (ENV in Retroviridae, and E2 in Coronaviridae) that are later processed into a transmembrane subunit (gp41 in the retrovirus HIV-<NUM>, and S2 in the coronavirus SARS-CoV) that is responsible for viral-induced membrane fusion, and a surface subunit that is responsible for the interaction with the cellular receptor/s. This study points to a similar mode of action for the two viral proteins, suggesting that anti-viral strategy that targets the viral-induced membrane fusion step can be adapted from HIV-<NUM> to SARS-CoV (see <FIG>). Recently the FDA approved Enfuvirtide, a synthetic peptide corresponding to the C-terminal heptad repeat of HIV-<NUM> gp41, as an anti-AIDS agent. Enfuvirtide and C34, another anti-HIV-<NUM> peptide, exert their inhibitory activity by binding to a leucine/isoleucine zipper-like sequence in gp41, thus inhibiting a conformational change of gp41 required for its activation. We suggest that peptides corresponding to the C-terminal heptad repeat of the S2 protein may serve as inhibitors for SARS-CoV entry.

The clinical observation was performed at Thammarakniwet Foundation, WAT Phrabaatnamphu, Lopburi Province, Thailand. The investigation was conducted under the supervision of Dr. Peerayot Trongsawad, MD, Director of AIDS Control Department, Bangkok Metropolis.

The study was conducted on <NUM> AIDS patients during August, <NUM> - August, <NUM>. All patients were consuming <NUM> liters of MRET activated water per day as a complimentary treatment in addition to the prescribed Anti-HIV medications. During the course of clinical observation all <NUM> patients were tested on a regular basis for CD4 counts and required to submit weekly reports regarding their health conditions. There was simultaneous observation of other group of AIDS patients during the same period of time (control group). They were on the same type of prescribed Anti-HIV medication, but without the complimentary consumption of MRET water.

First method: collection and analysis of the weekly health condition reports and CD4 counts reports; Second method: group interviews and personal interviews with patients which participate in this observation. <NUM> patients of the age between <NUM> and <NUM> years old were selected for the clinical trial. Summarizing the observation results we can indicate that in compliance with the studied gradations of AIDS patients health conditions <NUM> patients showed significant improvement and <NUM> patients did not show any improvement of their health condition. Some patients were selected to undergo two tests at the Bangkok Pathology Laboratories. One test was the reading of the level of CD4 counts (immune system) and the other was Viral Load (the amount of virus in the body) For CD4 reading, a healthy body should have a range of <NUM> - <NUM> cells / microliter.

For Viral Load, the instrument has the ability to measure from <NUM> - <NUM> copies / ml. The lower the number, the lesser the virus in the body, and subsequently lesser it attacks the patient's body.

In a first patient (Mr. Sa-ad), CD4 counts increased from <NUM> to <NUM> within <NUM> months of consumption of MRET activated water. His Viral Load was less than <NUM>. His skin recovered back from abnormal dark color to normal one.

In a second patient (Mr. Un-ruang), CD4 counts increased from <NUM> to <NUM> within <NUM> months of consumption of MRET activated water. His Viral Load was also less than <NUM>. His skin recovered back from abnormal dark color to normal one.

As to patients without MRET activated water, they did not show any significant improvement of their health condition.

We observed positive results of MRET water complimentary treatment for HIV patients during the clinical trial conducted at Thammarakniwet Foundation, WAT Phrabaatnamphu, Lopburi Province, Thailand. The recent research data allows to point to a similar mode of action for the two viral proteins, suggesting that anti-viral strategy that targets the viral-induced membrane fusion step can be adapted from HIV-<NUM> to SARS-CoV. We suggest that MRET water consumption by patients can lead to the modification of dielectric permittivity, electrical conductivity and hydrogen bonding of water-based medium in the human body. It leads to the significant change of van der Walls interactions and hydrogen bonding; those result in the inhibition and interruption of proper formation of virus spike proteins chains. Such scenario obviously disables coronavirus life sequence of attachment and fusion with human cell membranes. The same type of general mechanism can be adopted for other lines of bacteria and viruses.

Also provided is use of the activated water for preventing or reducing bacterial infection, which includes providing a subject at risk of bacterial infection; activating water or liquid by exposing the water or liquid to low frequency oscillations of <NUM> to <NUM> from an activation assembly that simultaneously applies an alternating electric current at a frequency between <NUM> to <NUM> and applies light at a wavelength between <NUM> and <NUM> to a polymer composition that in response produces the low frequency oscillations; and administering the activated water or liquid to the subject daily.

The significant protective properties of MRET water were confirmed by substantial decrease of Staphylococcus CFU (colony forming units) in homogenate of kidneys of mice on MRET water compared to control group of mice following the intra-peritoneal staphylococcal infection after the first <NUM>. For this purpose the kidneys of animals were dealt individually. The analysis of data in the beginning of experiments leads to the conclusion that significant decrease of pathogen's colonies in homogenate of kidneys of mice on MRET water begins only after <NUM> following the inoculation of S.

The significant protective properties of MRET water were confirmed by substantial decrease of Staphylococcus CFU (colony forming units) in homogenate of kidneys of mice on MRET water compared to control group of mice following the intra-peritoneal staphylococcal infection after the first <NUM>. For this purpose the kidneys of animals were dealt individually. The consumption of MRET water reduced the death rate from <NUM>% (control group) to <NUM>% (MRET groups) during the first <NUM> days of experiment. There was no case of animal death in all investigated groups within the first <NUM> after intra-peritoneal inoculation of Staphylococcus culture, which is a pretty standard result.

During the next <NUM> days <NUM>% of animals died in control group which is an expected result for such experimental procedure. There was no death case in both groups of mice that ingested MRET activated water and it is a very unusual result. Nevertheless, the main consequences of Staphylococcus infection do not manifest in death of animals as in case of oncology diseases. Staphylococcus bacteria affect the live systems and organs of the body. These pathogenic microorganisms cause inflammations, suppurations, abscesses, furuncles, quinsy, cepsical conditions, etc. That's why a detailed investigation of the process of stimulation by MRET water of phagocytes and of lymphoid organs of immune system of mice infected with S. aureus culture was conducted and is presented in this report.

The local inflammation was induced with the help of the inoculation of S. aureus culture into the hind left paw. The ordinary inflammatory reaction was observed in the group of mice on nonactivated water: the intensive reddening of the hind left paw. Both groups of mice on MRET water did not develop any reddening of the hind left paw inoculated with S. aureus culture. The results of this experiment confirm the fact of the substantial inhibition of inflammatory infection in case of the regular consumption of MRET water.

Phagocytosis is the main mechanism of natural resistance especially at the first stage of contagious process; it is a regular part of formation of the specific immune response. The most common methodology applied in the studies of the functional activity of phagocytes is the examination of their phagocytic (engulfing of alien cells) and oxygen dependent bactericidal activity. Phagocytic activity of neutrophils and macrophages is estimated based on Phagocytic Index (percentage of phagocytes which engulfed test-bacteria) and on Phagocytic Number (average number of test-bacteria engulfed by one phagocyte).

The cultures of S. aureus and Latex are usually used as test-bacteria. The oxygen-dependent bactericidal activity of phagocytes is studied with the help of NBT-test: an oxygen-dependent reduction of Nitro Blue Tetrazolium into an insoluble Diformazan of Nitro Blue Tetrazolium derivative by phagocytes. With the help of NBT-test it is possible to distinguish the activated phagocytes from the nonactivated ones. MRET water stimulated the phagocytic capacities of neutrophils of a peripheral blood and peritoneal macrophages increasing their phagocytic activity, particularly Phagocytic Index (<FIG>) and Phagocytic Number (<FIG>).

Claim 1:
A system (<NUM>) for the activation of water, the system comprising:
A) at least two activation tanks (<NUM>), each configured for storing at least <NUM> liters [<NUM>,<NUM> gallons] of water during activation and having a switch (<NUM>) that indicates the tank is full, wherein the switch (<NUM>) is operably connected to a controller with control panel (<NUM>) that instructs a valve to close when receiving a stop signal from the switch (<NUM>), thereby stopping the flow of water into the tank (<NUM>) when full;
B) an activation assembly (<NUM>) operably connected to each activation tank (<NUM>), each activation assembly (<NUM>) comprising:
i. a solenoid (<NUM>) comprising a column (<NUM>) wrapped in wiring (<NUM>), wherein the solenoid (<NUM>) is configured to generate a magnetic field between <NUM>,<NUM> A/m [<NUM>,<NUM> Oersteds] and <NUM>,<NUM>,<NUM> A/m [<NUM>,<NUM> Oersteds];
ii. a polymeric composition held within the column (<NUM>) and exposed to the magnetic field, the polymeric composition comprising a polymer having a linear chain length of at least <NUM> monomer units, and dispersed within the polymeric composition is a mixture having between <NUM> -<NUM> parts by weight per <NUM> parts by weight of polymer, at least one member selected from each of least two classes of:
a) a first class including a metal, metal oxide, metal nitrate and/or a metal sulfate,
b) a second class including an inorganic acid, and
c) a third class including an aminoaldehyde;
iii. a cluster of light emitted diodes (LEDs) (<NUM>) emitting at the polymer composition, an emission wavelength between <NUM> and <NUM>, the cluster of LEDS (<NUM>) configured to flash at a frequency between <NUM> and <NUM>; and
C) a means for powering (<NUM>) the activation assembly (<NUM>);
characterized in that:
each activation tank stores at least <NUM> liters [<NUM>,<NUM> gallons] of liquid during activation and each column holds at least <NUM>,<NUM><NUM> of the polymeric composition.